These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36580712)

  • 21. Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease.
    Niccoli Asabella A; Gigante AF; Ferrari C; Di Palo A; Rubini D; Mossa EP; Dagostino S; Pellicciari R; Defazio G; Rubini G
    Hell J Nucl Med; 2015; 18 Suppl 1():11-6. PubMed ID: 26665206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical gray matter and cerebral white matter atrophy and asymmetry in Parkinson's disease patients with normal cognitive precede.
    Jahanshahi A; Ghareaghaji N; Hassanpour S; Vafadar A; Mousavi S; Khezerloo D
    Int J Neurosci; 2023 Dec; ():1-6. PubMed ID: 38085250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.
    Kang JH; Irwin DJ; Chen-Plotkin AS; Siderowf A; Caspell C; Coffey CS; Waligórska T; Taylor P; Pan S; Frasier M; Marek K; Kieburtz K; Jennings D; Simuni T; Tanner CM; Singleton A; Toga AW; Chowdhury S; Mollenhauer B; Trojanowski JQ; Shaw LM;
    JAMA Neurol; 2013 Oct; 70(10):1277-87. PubMed ID: 23979011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?
    Jellinger KA
    J Neural Transm Suppl; 1999; 56():1-29. PubMed ID: 10370901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson's disease.
    Nabizadeh F; Sodeifian F; Pirahesh K
    Neurol Sci; 2022 Aug; 43(8):4745-4752. PubMed ID: 35508569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
    Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
    Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.
    Herb JN; Rane S; Isaacs DA; Van Wouwe N; Roman OC; Landman BA; Dawant BM; Hedera P; Zald DH; Neimat JS; Wylie SA; Donahue MJ; Claassen DO
    J Parkinsons Dis; 2016 May; 6(2):441-51. PubMed ID: 27164041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
    Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
    Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrastriatal
    Nicastro N; Garibotto V; Burkhard PR
    BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
    Roos DS; Twisk JWR; Raijmakers PGHM; Doty RL; Berendse HW
    J Neural Transm (Vienna); 2019 Nov; 126(11):1471-1478. PubMed ID: 31515655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multi-sequence MRI Study in Parkinson's Disease: Association Between Rigidity and Myelin.
    Cai J; Kim JL; Baumeister TR; Zhu M; Wang Y; Liu A; Lee S; McKeown MJ
    J Magn Reson Imaging; 2022 Feb; 55(2):451-462. PubMed ID: 34374158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered putamen and cerebellum connectivity among different subtypes of Parkinson's disease.
    Shen B; Pan Y; Jiang X; Wu Z; Zhu J; Dong J; Zhang W; Xu P; Dai Y; Gao Y; Xiao C; Zhang L
    CNS Neurosci Ther; 2020 Feb; 26(2):207-214. PubMed ID: 31730272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson's disease.
    Lyoo CH; Ryu YH; Lee MS
    J Neurol; 2011 Oct; 258(10):1871-6. PubMed ID: 21512741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
    Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-reported physical activity levels and clinical progression in early Parkinson's disease.
    Amara AW; Chahine L; Seedorff N; Caspell-Garcia CJ; Coffey C; Simuni T;
    Parkinsonism Relat Disord; 2019 Apr; 61():118-125. PubMed ID: 30554993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.